BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3379065)

  • 21. Location of the inhibitory region of smooth muscle myosin light chain kinase.
    Ikebe M; Maruta S; Reardon S
    J Biol Chem; 1989 Apr; 264(12):6967-71. PubMed ID: 2708351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional properties of peptides derived from seminalplasmin: binding to monospecific anti-seminalplasmin immunoglobulins G and calmodulin.
    Krauhs E; Preuss KD; Scheit KH
    Biol Chem Hoppe Seyler; 1990 Feb; 371(2):111-6. PubMed ID: 2334517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of 2-chloro-(epsilon-amino-Lys75)-[6-[4-(N,N- diethylamino)phenyl]-1,3,5-triazin-4-yl]calmodulin interactions with smooth muscle myosin light chain kinase and derived peptides.
    Török K; Trentham DR
    Biochemistry; 1994 Nov; 33(43):12807-20. PubMed ID: 7947686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of smooth muscle myosin light chain kinase by Ca2+/calmodulin-dependent protein kinase II: comparative study of the phosphorylation sites.
    Hashimoto Y; Soderling TR
    Arch Biochem Biophys; 1990 Apr; 278(1):41-5. PubMed ID: 2157362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of smooth muscle myosin light chain kinase activity by Ca2+/calmodulin-dependent, oligomeric-type modifications.
    Babiychuk EB; Babiychuk VS; Sobieszek A
    Biochemistry; 1995 May; 34(19):6366-72. PubMed ID: 7756265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence studies of the interaction of calmodulin with myosin light chain kinase.
    Johnson JD; Holroyde MJ; Crouch TH; Solaro RJ; Potter JD
    J Biol Chem; 1981 Dec; 256(23):12194-8. PubMed ID: 6895374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin-dependent autophosphorylation of smooth muscle myosin light chain kinase: intermolecular reaction mechanism via dimerization of the kinase and potentiation of the catalytic activity following activation.
    Sobieszek A
    Biochemistry; 1995 Sep; 34(37):11855-63. PubMed ID: 7547920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of smooth muscle myosin light chain kinase.
    Adelstein RS; Klee CB
    J Biol Chem; 1981 Jul; 256(14):7501-9. PubMed ID: 6894756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seminalplasmin. An endogenous calmodulin antagonist.
    Gietzen K; Galla HJ
    Biochem J; 1985 Aug; 230(1):277-80. PubMed ID: 2996494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-specific dephosphorylation of smooth muscle myosin light chain kinase by protein phosphatases 1 and 2A.
    Nomura M; Stull JT; Kamm KE; Mumby MC
    Biochemistry; 1992 Dec; 31(47):11915-20. PubMed ID: 1332778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smooth muscle myosin light chain kinase. Amino acid sequence at the site phosphorylated by adenosine cyclic 3',5'-phosphate-dependent protein kinase whether or not calmodulin is bound.
    Payne ME; Elzinga M; Adelstein RS
    J Biol Chem; 1986 Dec; 261(35):16346-50. PubMed ID: 3782123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of smooth muscle myosin light chain kinase by Ca2+-activated, phospholipid-dependent protein kinase.
    Ikebe M; Inagaki M; Kanamaru K; Hidaka H
    J Biol Chem; 1985 Apr; 260(8):4547-50. PubMed ID: 3157681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme kinetic characterization of the smooth muscle myosin phosphorylating system: activation by calcium and calmodulin and possible inhibitory mechanisms of antagonists.
    Sobieszek A
    Biochim Biophys Acta; 1999 May; 1450(1):77-91. PubMed ID: 10231558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of turkey gizzard myosin light chain. Kinase activity by dihydropyridine calcium antagonists.
    Movsesian MA; Swain AL; Adelstein RS
    Biochem Pharmacol; 1984 Dec; 33(23):3759-64. PubMed ID: 6548915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of melittin with the isolated myosin light chains.
    Malencik DA; Anderson SR
    Biochemistry; 1988 Mar; 27(6):1941-9. PubMed ID: 3378040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of chicken gizzard myosin light chain kinase by Ca2+/calmodulin is inhibited by autophosphorylation.
    Abe M; Hasegawa K; Hosoya H
    Cell Struct Funct; 1996 Jun; 21(3):183-8. PubMed ID: 8853555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A calorimetric study of Ca2+ binding to two major isotypes of bullfrog parvalbumin.
    Tanokura M; Yamada K
    FEBS Lett; 1985 Jun; 185(1):165-9. PubMed ID: 3873360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium- and magnesium-binding properties of oncomodulin. Direct binding studies and microcalorimetry.
    Cox JA; Milos M; MacManus JP
    J Biol Chem; 1990 Apr; 265(12):6633-7. PubMed ID: 2108959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of calmodulin with skeletal muscle myosin light chain kinase.
    Crouch TH; Holroyde MJ; Collins JH; Solaro RJ; Potter JD
    Biochemistry; 1981 Oct; 20(22):6318-25. PubMed ID: 6895471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.